Acquisition of carbapenemase-producing enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013

Eurosurveillance

Volumn 19, Issue 14, 2014, Pages

  Ruppe E ^a,b,c   Armand Lefevre L ^b   Estellat, C ^a,d   El Mniai, A ^a   Boussadia, Y ^a,d   Consigny, P H ^e   Girard, P M ^f   Vittecoq, D ^g   Bouchaud, O ^h   Pialoux, G ⁱ   Esposito Farese M ^a,d   Coignard, B ^j   Lucet, J C ^a,b,c   Andremont, A ^a,b,c   Matheron, S ^a,c  

^a BICHAT HOSPITAL   (France)

^b UNIVERSITÉ PARIS DIDEROT   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d INSERM   (France)

^e INSTITUT PASTEUR   (France)

^f HÔPITAL SAINT ANTOINE   (France)

^g BICÊTRE HOSPITAL   (France)

^h AVICENNE HOSPITAL   (France)

ⁱ HÔPITAL TENON   (France)

^j INSTITUT DE VEILLE SANITAIRE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; COTRIFAMOLE; GENTAMICIN; QUINOLONE DERIVATIVE; TETRACYCLINE;

ADULT; ARTICLE; BACTERIAL STRAIN; CARBAPENEMASES PRODUCING ENTEROBACTERIACEAE; ENTEROBACTERIACEAE; FEMALE; FOLLOW UP; HEALTH CARE SYSTEM; HUMAN; MIDDLE AGED; NEW DELHI METALLO BETA LACTAMASE 1 PRODUCING ENTEROBACTERIACEAE; OXA 181 PRODUCING ENTEROBACTERIACEAE; QUESTIONNAIRE; TRAVEL; YOUNG ADULT;

ADULT; BACTERIAL PROTEINS; BETA-LACTAMASES; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FECES; FEMALE; FRANCE; HUMANS; INDIA; MIDDLE AGED; RISK FACTORS; TRAVEL;

EID: 84898491697     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2014.19.14.20768     Document Type: Article

References (16)

1. Ruppé E, Armand-Lefèvre L, Lolom I, El Mniai A, Muller-Serieys C, Ruimy R, et al. Development of a phenotypic method for detection of fecal carriage of OXA-48-producing Enterobacteriaceae after incidental detection from clinical specimen. J Clin Microbiol. 2011;49(7):2761-2. http://dx.doi.org/10.1128/JCM.00055-11
2. Ruppé E, Hem S, Lath S, Gautier V, Ariey F, Sarthou JL, et al. CTX-M beta-lactamases in Escherichia coli from community-acquired urinary tract infections, Cambodia. Emerg Infect Dis. 2009;15(5):741-8. http://dx.doi.org/10.3201/eid1505.071299
3. Barbier F, Ruppé E, Giakkoupi P, Wildenberg L, Lucet J, Vatopoulos A, et al. Genesis of a KPC-producing Klebsiella pneumoniae after in vivo transfer from an imported Greek strain. Euro Surveill. 2010;15(1). pii: 19457.
4. Woerther PL, Burdet C, Chachaty E, Andremont A. Trends in Human Fecal Carriage of Extended-Spectrum beta-Lactamases in the Community: Toward the Globalization of CTX-M. Clin Microbiol Rev. 2013;26(4):744-58. http://dx.doi.org/10.1128/CMR.00023-13
5. Kennedy K, Collignon P. Colonisation with Escherichia coli resistant to "critically important" antibiotics: a high risk for international travellers. Eur J Clin Microbiol Infect Dis. 2010;29(12):1501-6. http://dx.doi.org/10.1007/s10096-010-1031-y
6. Ostholm-Balkhed A, Tärnberg M, Nilsson M, Nilsson LE, Hanberger H, Hallgren A. Travel-associated faecal colonization with ESBL-producing Enterobacteriaceae: incidence and risk factors. J Antimicrob Chemother. 2013;68(9):2144-53. http://dx.doi.org/10.1093/jac/dkt167
7. Paltansing S, Vlot JA, Kraakman ME, Mesman R, Bruijning ML, Bernards AT, et al. Extended-spectrum beta-lactamase-producing Enterobacteriaceae among travelers from the Netherlands. Emerg Infect Dis. 2013;19(8):1206-13. http://dx.doi.org/10.3201/eid1908.130257
8. Peirano G, Laupland KB, Gregson DB, Pitout JD. Colonization of returning travelers with CTX-M-producing Escherichia coli. J Travel Med. 2011;18(5):299-303. http://dx.doi.org/10.1111/j.1708-8305.2011.00548.x
9. Tängdén T, Cars O, Melhus A, Löwdin E. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob Agents Chemother. 2010;54(9):3564-8. http://dx.doi.org/10.1128/AAC.00220-10
10. Weisenberg SA, Mediavilla JR, Chen L, Alexander EL, Rhee KY, Kreiswirth BN, et al. Extended spectrum beta-lactamase-producing Enterobacteriaceae in international travelers and non-travelers in New York City. PLoS One. 2012;7(9):e45141. http://dx.doi.org/10.1371/journal.pone.0045141
11. Leverstein-van Hall MA, Stuart JC, Voets GM, Versteeg D, Roelofsen E, Fluit AC. [Carbapenem-resistant Klebsiella pneumoniae following foreign travel]. Ned Tijdschr Geneeskd. 2010;154(37):A2013. Dutch.
12. Leverstein-Van Hall MA, Stuart JC, Voets GM, Versteeg D, Tersmette T, Fluit AC. Global spread of New Delhi metallo-beta-lactamase 1. Lancet Infect Dis. 2010;10(12):830-1. http://dx.doi.org/10.1016/S1473-3099(10)70277-2
13. Poirel L, Hombrouck-Alet C, Freneaux C, Bernabeu S, Nordmann P. Global spread of New Delhi metallo-beta-lactamase 1. Lancet Infect Dis. 2010;10(12):832. http://dx.doi.org/10.1016/S1473-3099(10)70279-6
14. Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis. 2011;11(5):355-62. http://dx.doi.org/10.1016/S1473-3099(11)70059-7
15. Cloodt H. Air transport recovers in 2010. Luxembourg: Eurostat; 2012.
16. European Centre for Disease Prevention and Control (ECDC). Carbapenemase-producing bacteria in Europe: interim results from the European Survey on carbapenemase-producing Enterobacteriaceae (EuSCAPE) project. Stockholm: ECDC; 2013.